Close Menu

Vela Diagnostics

NEW YORK (GenomeWeb News) – Agilent Technologies said this week that it has appointed Ron Nersesian to be company president as well as chief operating officer, effective immediately.

Great Basin this week announced the opening of a new manufacturing facility for its recently launched molecular diagnostics system and first test.

Great Basin said that it has hired Lisa Weingartner as regional business manager for the southeast US region and Richard Corbiel as applications specialist.

Scientists from Great Basin Scientific and three university medical schools and hospitals have published research demonstrating that Great Basin's molecular diagnostic test for Clostridium difficile is as sensitive and specific as a competing molecular test based on real

Great Basin this week named six distributors in Europe and one in New Zealand for its recently commercialized molecular diagnostic test for Clostridium difficile.

Great Basin said this week that it has hired several new employees to support commercialization of the company's first molecular diagnostic assay, a test for Clostridium difficile.

Great Basin said this week that it has received 510(k) clearance from the US Food and Drug Administration for its first molecular diagnostic test, an assay for Clostridium difficile.

NEW YORK (GenomeWeb News) – Following Hologic's $3.7 billion agreement to acquire Gen-Probe, the molecular diagnostics space may be on the verge of some industry consolidation, according to investment analysts.

NEW YORK (GenomeWeb News) – Great Basin today announced it has received 510(k) clearance from the US Food and Drug Administration for its first molecular diagnostic test for Clostridium difficile.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.